Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
DRMA · NASDAQ · Pharmaceutical Preparations
$0.5095−0.0225 (−4.23%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Dermata Therapeutics (DRMA) · oqro.io/stocks/DRMA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 2, 2026
Bigger Michael now owns 8.4% of DRMA as a passive investorSourceInsider trade · Traded Jun 16, 2026 · Filed Jun 16, 2026
Director sold ~$13 of DRMA shares in the open marketSourceInsider trade · Traded Feb 17, 2026 · Filed Mar 17, 2026
Officer purchased ~$1.3K of DRMA shares in the open marketSource